Greg Simon

Greg Simon is the President of MediMergent, LLC and is responsible for all strategies related to the collection and analysis of Real World Data for Pharma, Payers, Prescribers, and Regulators. He is a knowledgeable analyst of emerging trends in healthcare, information technology, innovative drug research and development, and patient advocacy.

He previously was the President of the Biden Cancer Initiative at the Biden Foundation. While at the Biden Foundation, Greg and his team worked across the Task Force, academia, and the private sector to create over seventy innovative collaborations.

Prior to this position, he was the Executive Director of the White House Cancer Moonshot Task Force, a position created by President Barack Obama and for which he was chosen by Vice President Joe Biden in March 2016. As Executive Director, Greg assembled and led a team of eight professionals to support the work of the Vice President in developing and promoting the goals of the Cancer Moonshot in numerous meetings and presentations and to coordinate the work of the Task Force comprised of twenty cabinet and sub-cabinet offices.